News Novartis trumpets long-term data for Cosentyx in psoriasis Novartis is hoping that new real world data will help its psoriasis drug Cosentyx stay ahead of rivals.
News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News NICE recommends funding for three thyroid cancer drugs Eisai's drug finally funded after two year delay
News Doubts over BACE drugs after Merck ends Alzheimer's trial Decision comes a year after Merck axed EPOCH verubecestat trial
News AI giant Anthropic buys Coefficient Bio for $400m Anthropic has continued its push into the healthcare sector by acquiring New York startup Coefficient Bio.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
